ApicHope(SZ:300723) Xin Lang Cai Jing·2025-10-23 02:57Group 1 - The core point of the news is that Yipinhong Pharmaceutical Group experienced a decline in stock price, dropping by 5.05% to 53.20 CNY per share, with a trading volume of 254 million CNY and a turnover rate of 1.12%, resulting in a total market capitalization of 24.03 billion CNY [1] - Yipinhong Pharmaceutical, established on February 4, 2002, and listed on November 16, 2017, is located in Guangzhou, Guangdong Province. The company focuses on the research, production, and sales of its own pharmaceuticals, as well as the sales of agent pharmaceuticals [1] - The company's main business revenue composition includes children's medicine at 61.12%, chronic disease medicine at 22.71%, and other products at 16.17% [1] Group 2 - From the perspective of major fund holdings, the Dongfang Alpha Fund has a significant position in Yipinhong, with the Dongfang Alpha Health Industry Mixed Fund A (024357) holding 15,700 shares, accounting for 7.76% of the fund's net value, making it the third-largest holding [2] - The Dongfang Alpha Health Industry Mixed Fund A (024357) was established on June 12, 2025, with a latest scale of 9.5635 million CNY and has experienced a loss of 1.01% since inception [2] - The fund manager, Meng Yu, has been in the position for 1 year and 330 days, with total fund assets of 169 million CNY, achieving a best fund return of 22.64% and a worst fund return of -0.41% during the tenure [2]